Public perception of innovative therapies and biopharmaceuticals in Poland and Europe
Komitet Biotechnologii PAN ; Instytut Chemii Bioorganicznej PAN
Several reports and surveys of the perception of red biotechnology uses conducted in recent years show the complexity of European’s attitude to innovative therapies which might be used in medicine. Polish people, as well as the rest of European nations in general, support the development of gene therapy or pharmacogenetics, whereas the issues of stem cells research and uses of genetic information are still under discussion. The results of various questionnaires prove that a rise of the optimism level in this matter is necessary. It occurred that in order to build public acceptability and confidence in biotechnology policy, it is crucial to ensure the society that moral and ethical aspects are taken into consideration.
Biotechnologia, vol.77, 2 (2007)-.
0860-7796 ; oai:rcin.org.pl:87121
Biblioteka Instytutu Chemii Bioorganicznej PAN
Licencja Creative Commons Uznanie autorstwa-Na tych samych warunkach 4.0
Instytut Chemii Bioorganiczneji Polskiej Akademii Nauk
Instytut Chemii Bioorganiczneji Polskiej Akademii Nauk
2 paź 2020
6 gru 2019
353
https://rcin.org.pl/ichb/publication/113505
Nazwa wydania | Data |
---|---|
Odbiór społeczny innowacyjnych terapii i biofarmaceutyków w Polsce i Europie | 2 paź 2020 |
Borkowska, Bożenna
Ziółkowski, Piotr Babula- Skowrońska, Danuta Kaczmarek, Małgorzata Cieśla, Agata Sadowski, Jan
Nowak, Jacek K.